WallStreetZenWallStreetZen

NASDAQ: CSBR
Champions Oncology Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Champions Oncology earnings were $6.4M for the trailing 12 months ending Jan 31, 2025, with N/A growth year over year. The latest CSBR earnings report on Jan 31, 2025 announced Q1 2025 earnings of $4.5M, up 517.4% from last quarter. For the last reported fiscal year 2024 ending Apr 30, 2024, CSBR reported annual earnings of -$7.3M, with 36.4% growth.

CSBR past earnings growth

How has CSBR's earnings growth performed historically?

Company
N/A
Industry
11.8%
Market
63.03%
CSBR's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CSBR's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

CSBR earnings history

Current Revenue
$58.6M
Current Earnings
$6.4M
Current Profit Margin
11%

CSBR Return on Equity

Current Company
656.7%
Current Industry
-2%
Current Market
34.1%
CSBR's Return on Equity (656.7%)... subscribe to Premium to read more.
High Return on Equity Performance

CSBR undefined

Current Company
24%
Current Industry
-0.4%
CSBR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CSBR announces earnings.

CSBR undefined

Current Company
59.51%
Current Industry
5.9%
CSBR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CSBR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CSBR$8.10M$6.43M+282.31%$0.47
TLSA-$17.15M-$17.69MN/A-$0.17
OBIO-$60.06M-$61.02MN/A-$1.66
ENTA-$94.42M-$104.93MN/A-$4.95
EDIT-$245.35M-$237.09MN/A-$2.88
View Top Biotech Stocks

Champions Oncology Earnings Reports & History FAQ

What were Champions Oncology's earnings last quarter?

On CSBR's earnings call on Invalid Date, Champions Oncology (NASDAQ: CSBR) reported Q4 2024 earnings per share (EPS) of $0.33, up 273.68% year over year. Total CSBR earnings for the quarter were $4.50 million. In the same quarter last year, Champions Oncology's earnings per share (EPS) was -$0.19.

If you're new to stock investing, here's how to buy Champions Oncology stock.

Is Champions Oncology profitable or losing money?

As of the last Champions Oncology earnings report, Champions Oncology is currently profitable. Champions Oncology's net profit (also called net income) for the twelve months ending Jan 31, 2025 was $6.43 million, a 166.07% decrease year over year.

What was CSBR's earnings growth in the past year?

As of Champions Oncology's earnings date in Invalid Date, Champions Oncology's earnings has grown year over year. CSBR earnings in the past year totalled $6.43 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.